Afsoun Pourya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Afsoun Pourya has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ali Pooria
Department of Cardiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
2 shared publications - Alireza Gheini
Department of Cardiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
1 shared publication - Morteza Azadbakht
Department of Surgery, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
1 shared publication Parham Khoshdani‐Farahani
Department of surgery Faculty of Medicine Lorestan University of Medical Science Khorramabad Iran
1 shared publication
Latest Publications
- Open Access
- 11 March 2020
- Published by Wiley in Clinical Case Reports
- Vol. 8 (4) , 606-611
Sigmoid volvulus after CABG surgery
We report a case of a geriatric patient who underwent CABG and developed sigmoid volvulus (SV) with recurrence. SV is a rarely reported complication of CABG. Timely diagnosis, management, and follow‐up are strictly advised, particularly in geriatric patients. Immediate surgical measures are required to prevent volvulus‐associated ischemia.
- 11 March 2020
- Published by Wiley in Clinical Case Reports
- Vol. 8 (4) , 606-611
Open AccessSigmoid volvulus after CABG surgery
We report a case of a geriatric patient who underwent CABG and developed sigmoid volvulus (SV) with recurrence. SV is a rarely reported complication of CABG. Timely diagnosis, management, and follow‐up are strictly advised, particularly in geriatric patients. Immediate surgical measures are required to prevent volvulus‐associated ischemia.
- 27 February 2019
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (9) , 14927-14940
Animal‐ and human‐based evidence for the protective effects of stem cell therapy against cardiovascular disorders
The increasing rate of mortality and morbidity because of cardiac diseases has called for efficient therapeutic needs. With the advancement in cell‐based therapies, stem cells are abundantly studied in this area. Nearly, all sources of stem cells are experimented to treat cardiac injuries. Tissue engineering has also backed this technique by providing an advantageous platform to improve stem cell therapy. After in vitro studies, primary treatment‐based research studies comprise small and large animal studies. Furthermore, these studies are implemented in human models in the form of clinical trials. Purpose of this review is to highlight the animal‐ and human‐based studies, exploiting various stem cell sources, to treat cardiovascular disorders.
- 27 February 2019
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (9) , 14927-14940
Animal‐ and human‐based evidence for the protective effects of stem cell therapy against cardiovascular disorders
The increasing rate of mortality and morbidity because of cardiac diseases has called for efficient therapeutic needs. With the advancement in cell‐based therapies, stem cells are abundantly studied in this area. Nearly, all sources of stem cells are experimented to treat cardiac injuries. Tissue engineering has also backed this technique by providing an advantageous platform to improve stem cell therapy. After in vitro studies, primary treatment‐based research studies comprise small and large animal studies. Furthermore, these studies are implemented in human models in the form of clinical trials. Purpose of this review is to highlight the animal‐ and human‐based studies, exploiting various stem cell sources, to treat cardiovascular disorders.